108 related articles for article (PubMed ID: 21474413)
1. Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.
Dahabreh IJ; Murray S
Cancer Epidemiol; 2011 Dec; 35(6):503-9. PubMed ID: 21474413
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
Lee SC; Hou MF; Hsieh PC; Wu SH; Hou LA; Ma H; Tsai SM; Tsai LY
Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
4. Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.
Chen W; Yang H; Tang WR; Feng SJ; Wei YL
Asian Pac J Cancer Prev; 2014; 15(22):9643-7. PubMed ID: 25520082
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
[TBL] [Abstract][Full Text] [Related]
6. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
[TBL] [Abstract][Full Text] [Related]
7. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
8. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
Tao W; Wang C; Han R; Jiang H
Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
[TBL] [Abstract][Full Text] [Related]
9. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.
Montgomery KG; Gertig DM; Baxter SW; Milne RL; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1109-11. PubMed ID: 14578152
[TBL] [Abstract][Full Text] [Related]
10. Association of HER2 codon 655 polymorphism with ovarian cancer.
Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
[TBL] [Abstract][Full Text] [Related]
11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
12. The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.
Rutter JL; Chatterjee N; Wacholder S; Struewing J
Epidemiology; 2003 Nov; 14(6):694-700. PubMed ID: 14569185
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
15. HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.
Lu S; Wang Z; Liu H; Hao X
Breast Cancer Res Treat; 2010 Dec; 124(3):771-8. PubMed ID: 20401632
[TBL] [Abstract][Full Text] [Related]
16. HER2 polymorphism and breast cancer risk in Portugal.
Pinto D; Vasconcelos A; Costa S; Pereira D; Rodrigues H; Lopes C; Medeiros R
Eur J Cancer Prev; 2004 Jun; 13(3):177-81. PubMed ID: 15167216
[TBL] [Abstract][Full Text] [Related]
17. Her2 genotype and breast cancer progression in Korean women.
An HJ; Kim NK; Oh D; Kim SH; Park MJ; Jung MY; Kang H; Kim SG; Lee KP; Lee KS
Pathol Int; 2005 Feb; 55(2):48-52. PubMed ID: 15693849
[TBL] [Abstract][Full Text] [Related]
18. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
[TBL] [Abstract][Full Text] [Related]
19. Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
Cardoso YMN; Resque RL; Yoshio D; B Miranda AR; Secco M; Do N Rodrigues AS
Asian Pac J Cancer Prev; 2023 Jan; 24(1):157-162. PubMed ID: 36708564
[TBL] [Abstract][Full Text] [Related]
20. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.
Dahabreh IJ; Linardou H; Bouzika P; Varvarigou V; Murray S
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1840-7. PubMed ID: 20615891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
